v-Ha-ras has been demonstrated previously to induce neuroendocrine dierentiation of medullary thyroid carcinoma (MTC, malignant C cell tumor) cell lines. The potential role of ras mediated signaling in neuroendocrine cells in vivo has been investigated by expressing v-Ha-ras under control of the neural/ neuroendocrine speci®c calcitonin/calcitonin gene-related peptide (CGRP) promoter. Five independent mouse lineages were derived following germ line insertion of the transgene. Four of the ®ve lineages consistently express the transgene; neuroendocrine expression is found in three of the ®ve lineages as both spliced and full length messages. Phenotypically, the mice expressing rascal have shortened lifespans primarily due to the high incidence of MTCs between 6 months to a year of age. C-cell hyperplasia is demonstrated in several mice in the absence of gross evidence of tumor formation. Histopathological and ultrastructural analyses demonstrate typical features of MTCs including prominent immunohistochemical staining for calcitonin and dense-core neurosecretory-type granules. In addition, four of 22 tumors co-express thyroglobulin (a non-neuroendocrine follicular epithelial cell marker) and calcitonin (a neuroendocrine marker) in a subset of the tumor cells. The rascal transgenic mouse provides a unique model for investigating the sequential pathogenesis of MTC and possibly also for elucidating the relationship between MTC and mixed medullary-follicular carcinomas.
Introduction
The ras family of proto-oncogenes was identi®ed originally as the related transforming genes of the Harvey and Kirsten strains of murine sarcoma viruses (Barbacid, 1987) . DNA transfection experiments later demonstrated that cellular homologues of the retroviral oncogenes are mutated in a variety of human cancers (Barbacid, 1987; Bos, 1989) . The family is composed of three members, c-Ha-ras, c-Ki-ras and N-ras, which are structurally and functionally conserved and act as members of signal transduction pathways (Lowy and Willumsen, 1993) . Mutation of ras family members at speci®c residues activate them as oncogenes capable of transforming cells both in vivo and in vitro. v-Ha-ras, the viral homologue of c-Ha-ras, is mutated at residues 12 and 59 (Dhar et al., 1982) . Transfection of v-Ha-ras into neural and neuroendocrine cell lines can lead to morphological and biochemical changes consistent with cell dierentiation. In a rat pheochromocytoma line, PC-12, microinjection of v-Ha-ras triggered neurite extension. Similarly, in a human medullary thyroid carcinoma (MTC) line, TT, and a classic small cell lung cancer (SCLC) line, DMS53, transfection of v-Ha-ras augmented synthesis of calcitonin (a marker of welldierentiated neuroendocrine cells) and decreased the rate of cell proliferation (Bar-Sagi and Feramisco, 1985; Nakagawa et al., 1987; Mabry et al., 1989) . In a dierent classic SCLC line, H249, v-Ha-ras induced a non-small cell phenotype, with associated growth factors and receptors (Falco et al., 1990) , suggesting that the induction of cell dierentiation may not be limited exclusively to the neuroendocrine phenotype. When activated ras is expressed in mice as a transgene, tumors can arise in tissues dependent upon the promoter used to drive its expression (Quaife et al., 1987; Mangues et al., 1990) . For example, activated Ki-ras driven by the thyroglobulin promoter leads to thyroid follicular adenomas and adenocarcinomas in goitrogen stimulated mice (Santelli et al., 1993) .
The thyroid is composed of two characteristic endocrine cell types. The follicular epithelial cells concentrate iodide and ultimately produce thyroid hormone from the follicular thyroglobulin stores. The parafollicular neuroendocrine cells, also known as Ccells, are localized adjacent to the follicular epithelial cells and help to regulate serum calcium levels through synthesis and secretion of calcitonin. In the mature thyroid, expression of thyroglobulin is con®ned to the follicular epithelial cells, whereas expression of calcitonin and its splice site variant CGRP is restricted to C-cells. This dichotomy in gene expression by the two dierent cell types is believed to re¯ect their distinct embryological origins. During development, the thyroid forms from the fusion of a central anlage of foregut endoderm with paired lateral anlagen known as the ultimobranchial bodies. Quail-chick embryonal transplantation experiments demonstrated that C-cells migrate from neural crest to the ultimobranchial body (Polak et al., 1974) . However, human MTCs have been described in which ultrastructural and histochemical features of both parafollicular and follicular epithelial cells are expressed within the same cell (Holm et al., 1987; Kovacs et al., 1994) . The existence of these tumors, termed mixed medullary and follicular carcinomas, forms the basis for the proposition that C-cells and follicular cells might share a common embryological origin (Ljungberg et al., 1983; SobrinhoSimoes et al., 1985) .
Expression of transfected v-Ha-ras in MTC cell lines was previously shown to promote neuroendocrine dierentiation in vitro (Nakagawa et al., 1987) . In the present study, the potential role of ras mediated signaling in thyroid neuroendocrine cells in vivo has been investigated by expressing v-Ha-ras under control of calcitonin/CGRP promoter; this promoter has been shown to limit transgene expression to neuroendocrine and neural cells (Bennett and Amara, 1992; Baetscher et al., 1991) . In the present study, the mice which result acquire C-cell hyperplasia and slow growing unilateral and bilateral thyroid tumors. A subset of cells within some of the tumors are demonstrated to co-express thyroglobulin and calcitonin. These observations suggest that v-Ha-ras expression might occur in some animals in a bipotential stem cell leading to tumors with both neuroendocrine and non-neuroendocrine cell phenotypes. In summary, rascal transgenic mice provide a novel murine model of MTC which occurs more rapidly and in a much higher percentage of the animals than previously described rat models of MTC (DeLellis, 1994) . Analyses of transgene expression in these mice could also be useful for elucidating pathways of thyroid endocrine cell lineages.
Results

The rascal lineages
The rascal transgene, shown schematically in Figure 1 , consists of three components; 2041 base pairs of the calcitonin/CGRP gene from 71934 to +107 bases around the transcriptional start site (at +1), 1013 bases of v-Ha-ras containing the coding sequence of p21, and 847 bases containing the early mRNA polyadenylation signals of the SV40 T antigen (Amara et al., 1984; Kimura et al., 1995; Berk and Sharp, 1978; Dhar et al., 1982) . Five independent lineages have been derived. Phosphorimage analysis of Figure 1 The rascal construct. The rascal construct as depicted was completely sequenced to con®rm its integrity. The rat calcitonin/CGRP promoter contains 1927 bases 5' of the transcriptional start site and 108 bases of the ®rst exon linked to v-Ha-ras 64 bases 5' of the initiator AUG. 814 bases of v-Ha-ras p21 coding sequence plus 194 bases of retroviral sequence were joined to 845 bases of the SV40 genome encompassing the small T splice acceptor site and polyadenylation signals. Two rascal transcripts were detected by both Northern blotting and by RT ± PCR: one transcript corresponding to the full-length (intronless) transgene; and a second transcript *500 bp smaller. The smaller (364 bp) RT ± PCR product was sequenced and found to match the transgene sequence except for a 506 base deletion beginning 6 bases 3' of the translational terminator and ending at the SV40 small t intron splice acceptor site. Therefore, the smaller transcript corresponds to alternatively spliced rascal which retains all of the p21 v-Ha-ras coding and polyadenylation sequences Southern blots indicates that the lineages contain from one to 19 copies of the transgene per haploid genome (Table 1) . Analysis has been carried out largely on lineages 2, 3 and 5; lineage 2 has normal fertility and transmits the transgene in a Mendelian fashion while lines 3 and 5 have reduced fertility possibly due to the loss of transgenic embryos. Hemizygote crosses with non-transgenic mice yield less than 50% transgenic ospring in lineages 3 and 5 (Table 1) . Lineages 1 and 4 produced few fertile transgenic ospring and were discontinued.
Transgene expression
RT ± PCR analyses demonstrate that the transgene is expressed in brain, lung, and thyroid in lineage 3 ( Figure  2 ), consistent with the expected distribution of gene expression driven by the calcitonin/CGRP promoter. The distribution of rascal expression in lineage 5 is similar to that of lineage 3. The rascal mRNA levels in the lung and brain of lineage 3 are lower than those in Figure 2 rascal transgene expression. The upper panel presents an ethidium stained gel of rascal RT ± PCR products. Total RNA prepared from grossly normal organs of a lineage 3 transgenic mouse was treated with DNAse prior to reverse transcription followed by PCR ampli®cation using the R8 ± 695 primer pair as described in detail in Materials and methods. Lanes shown to correspond to: H, heart; B, brain; K, kidney; Lv, liver; Lg, lung; T, thyroid; S, spleen; M, molecular weight markers. The middle panel shows the corresponding RT ± PCR Southern blot of the upper gel probed using the 364 bp rascal insert. Note that the strongest signal occurs in thyroid (T), followed by a moderate signal in lung (Lg). A weak but detectable signal is apparent in brain (B) at longer exposures (data not shown). The lower panel demonstrates the ethidium stained gel of RT ± PCR for expression of a housekeeping positive control gene: beta-actin. Actin ampli®cation from the same reverse transcription reactions as used for rascal PCR demonstrates that actin ampli®ed with approximately equal eciency in each sample, supporting approximately equal loading of mRNA in each RT thyroid and are not evident in ethidium stained agarose gels ( Figure 2 ). The expressed gene is spliced, as shown by RT ± PCR (Figure 2) analyses. The pair of primers used (695 and R8) was selected to amplify only the transgene: the forward PCR primer localizes within the ras structural gene and the reverse primer hybridizes within the SV40 polyadenylation signal (see Figure 1 ). RT ± PCR reveals a predominant ampli®cation product approximately 500 bases shorter that the predicted product corresponding to the full length transcript (thyroid (T) lane, Figure 2 ). DNA sequencing demonstrated that this truncated RT ± PCR product is correctly spliced mRNA (Figure 1 ): the splice donor site being located six bases 3' of the translational terminator, analogous to a c-Ha-ras site identi®ed previously (Cohen et al., 1989) , and the splice acceptor site being identical to that for removing the SV40 small T intron (Berk and Sharp, 1978) . When blots are prepared from RT ± PCR products and probed with the smaller 364 base pair ampli®cation product, the PCR product from the spliced form is detected in both lung (Figure 2 middle) and brain (on longer exposures, data not shown).
In situ hybridization analysis using transgene-speci®c antisense cRNA probes demonstrates strong transgene Figure 3a and b, a strongly positive signal is seen in a section hybridized with the antisense cRNA which is complementary to tissue mRNAs; in contrast, an immediate serial section ( Figure 3c ) probed with the corresponding sense cRNA is devoid of any hybridization signal ( Figure 3d ). Northern analysis of total RNA from 10 thyroid tumors taken from lineages 3 and 5 reveal two major bands of approximately 1.9 and 1.4 kB, consistent with expected sizes of the full length transcript and spliced variant predicted from the rascal sequence and the appearance of two ampli®cation products (Figure 3e ).
Pathological eects of transgene expression
The most notable eect of rascal expression is the consistent appearance of uni-and bilateral thyroid tumors. By external examination of the mice, these tumors arise between 6 months and one year of life in 85% of hemizygous lineage 3 (n=20) and 93% of hemizygous lineage 5 (n=33) mice. Lineages 1, 2, and 4 also demonstrate thyroid tumors ( Table 1 ). The mice live for months carrying tumors which approach up to 5% of their body weight, and many survive for over a year.
The tumors enlarge from small nodules of C-cell hyperplasia into locally invasive and hemorrhagic neoplasms ( In brief, all 22 rascal thyroids containing tumors which were examined by immunoperoxidase analyses were positive for calcitonin: 17 of 22 demonstrated moderate to strong calcitonin immunostaining of over 75% of tumor cells (++++); three of 22 tumors had 50 ± 75% (+++) of tumor cells moderately positive for calcitonin; and two of 22 tumors had 5 ± 25% (+) and 25 ± 50% (++) of tumor cells weakly to strongly positive for calcitonin. All calcitonin-positive tumor cells were also positive for CGRP. There was no detectable immunostaining for bombesin-like peptide immunoreactivity (Sunday et al., 1988) . Four thyroids from normal littermates (ages 15, 21, and 22 months) and one non-expressing lineage 2 animal (age 19 months) which were examined by calcitonin immunostaining had no evidence of C-cell hyperplasia or neoplasia (data not shown).
In four of the 22 tumors, all of which express calcitonin in over 50 ± 75% of tumor cells and coexpress calcitonin and thyroglobulin in the same cells, there are multiple small nests of tumor cells as determined by immunostaining of thin immediately adjacent serial sections ( Figure 5) . One of the four animals exhibiting coexpression of calcitonin and thyroglobulin (Figure 5a ± c) was the only lineage 2 mouse with a grossly palpable thyroid tumor (a section of which is demonstrated to express the transgene in Figure 3b ). The low incidence of thyroid tumors in lineage 2 transgenics is speculated to be due to lower levels of transgene expression in this lineage, in which lung tissue from three adult transgenic mice without a phenotype was found to be negative for transgene expression (data not shown). In this one lineage 2 animal with a grossly evident tumor nodule, a large cord of invasive MTC was almost entirely calcitonin ). An island of normal parathyroid tissue is present on the right hand side of the same thyroid lobe (long arrow, P) (H&E, 633 magni®cation); (B) At higher power, the C-cells show nuclear pleiomorphism and multiple small vacuoles (H&E, 6160); (C) Mild to moderate calcitonin positivity is present in over 25 ± 50% of the C-cells (left), including multiple cells forming vacuoles (small arrows); calcitonin antigen preabsorption of antiserum (right, 10 mg/ml) abrogates speci®c immunoreactivity in a 3 mm serial section (methyl green counterstain, 6100) (D ± J) Thyroid from 14 month old mouse with unilateral thyroid tumor. (D) At low power magni®cation, a large cyst is demonstrated within a grossly palpable MTC, which is growing as papillary structures projecting into the cyst lumen. The cyst lymen (C) is ®lled with proteinaceous material and some hemorrhage. Amyloid matrix is present within a tumor papilla on the right (arrow) (H&E, 633); (E) Central necrosis is present in tumor nodules with associated neutrophils and hemorrhage (arrows) (H&E, 666); (F) At higher power, malignant features of tumor cells include nuclear pleiomorphism, high nuclear to cytoplasmic ratio, and a high frequency of mitoses (arrow) (H&E, 6160). (G) Thyroglobulin positive follicles (arrows) adjacent to MTC nests (left, 680); thyroglobulin preabsorption of same antiserum (10 mg/ml) on immediately serial section shows greatly reduced immunostaining of follicles (right, 680) . Note that the less than complete abrogation of thyroglobulin immunoreactivity by antigen preabsorption is likely to be due to two factors: 1. the rabbit polyclonal antiserum was made to human thyroglobulin, but we were analysing murine thyroids and antiserum pre-absorption was carried out with the commercially available bovine thyroglobulin; and 2. the absorption was carried out with soluble thyroglobulin, whereas the antigen available in tissue sections is paraformaldehyde ®xed in the tissue sections, which could alter epitope speci®city. In another transgenic mouse, multiple nests of tumor cells were positive for both calcitonin and thyroglobulin immunostaining. Thin serial sections are shown in Figure 5d and e, which are stained for calcitonin and thyroglobulin, respectively. Calcitoninpositive tumor cells formed occasional follicular-like structures (Figure 5d ).
The mice are otherwise relatively normal in body and organ weights when compared to non-transgenic littermates. Lineage 3 and lineage 5 are similar in the high incidence of thyroid tumors and consistently high expression of the transgene in thyroid and lung. Two lineage 2 adult transgenic mice with no evidence of histopathology had low to undetectable levels of expression of rascal in normal lung and thyroid; lineage 2 was associated with a low incidence of C cell hyperplasia (two of 43 mice autopsied) and one small thyroid tumor (out of 43 mice autopsied). Lineages 1 and 4 expressed the transgene consistently at high levels and developed thyroid tumors but had to be discontinued due to low fertility.
In addition, two transgenic mice developed adrenal medullary tumors consistent with pheochromocytomas, one transgenic mouse (the lineage one founder) developed a widely metastatic abdominal lymphoma, and 14 transgenic mice (derived from all lineages) developed primary lung carcinomas which were both non-neuroendocrine and neuroendocrine in phenotype (Sunday, Haley, Mu, and Hatzis, manuscript in preparation) . This distribution of tumors is consistent with the known distribution of calcitonin/CGRP gene expression in adrenal and lung. There were no tumors observed in the central nervous system, pituitary, peripheral nerves, or pancreas, in spite of known calcitonin/CGRP gene expression in these tissues.
Ultrastructural analyses
Transmission electron microscopy was carried out on one typical MTC nodule to further characterize the thyroid tumors arising in rascal transgenic mice ( Figure  6 ). Most of the tumor examined was composed of cells containing abundant well-developed dense-core gran- ules (Figure 6a and b) . Although several follicular structures were evident in other electron micrographs of this tumor nodule, it could not be determined whether these were pre-existing normal follicles compressed by the growing tumor or were part of the tumor per se (data not shown). In this limited preliminary ultrastructural analysis, we did not observe any cells with ultrastructural features of both neuroendocrine and follicular epithelial cells.
Discussion
The present study demonstrates the development of MTCs in rascal transgenic mice which express v-Haras under control of the calcitonin/CGRP promoter. These mice develop C-cell hyperplasia with dysplasia as early as 5 months of age and MTCs appear in 85 ± 93% of mice over 6 months of age. Tumors immunostain for calcitonin and CGRP and contain dense-core neurosecretory-type granules, consistent with classical descriptions of human MTC. This represents an interesting and useful animal model of MTC occurring at high prevalence, which up until now has been studied mainly in several dierent strains of rat (DeLellis, 1994) . In addition, transgenic mice expressing the SV40 large T antigen (Tag) under control of the calcitonin/CGRP promoter rapidly developed thyroid tumors which were probably MTCs, but the mice were short-lived, surviving for less than a month due to widely metastatic thyroid carcinomas (Baetscher et al., 1991) . Other transgenics developing MTCs include the double Rb/p53 knockout mice (Harvey et al., 1995) and c-mos over-expressing transgenic mice (Schulz et al., 1992) . Similar to these two latter transgenic mouse models, rascal transgenic mice have a long latency period for tumor development (months to years) (Harvey et al., 1995; Schulz et al., 1992) and can demonstrate evidence of C-cell hyperplasia early in their course (Schulz et al., 1992) . However, there is a higher incidence of MTC in rascal transgenics as compared to the other two transgenic mouse models: 68% or less of c-mos transgenics and 37% or less of Rb/p53 knockout mice develop MTCs. Furthemore, the low incidence of pheochromocytomas in rascal transgenics (two mice from separate lineages out of 104 mice autopsied in total) suggests that these mice might provide a model for sporadic MTC rather than MTC linked to multiple endocrine neoplasia (MEN) syndromes. In contrast, Rb/p53 knockout mice and c-mos transgenics have a high incidence of both MTC and pheochromocytomas.
Our observations indicate that v-Ha-ras can be an initiating event in oncogenesis of thyroid C-cells and that MTC might arise from v-Ha-ras transformed Ccells in mice. In humans, however, activated c-Ha-ras is not associated with MTC (Moley et al., 1991) ; rather, c-Ha-ras, Ki-ras, and N-ras have been shown to be mutated in signi®cant percentages of thyroid follicular neoplasms (Bos, 1989; Manenti et al., 1994) . It is of note that c-mos transgenic mice develop MTCs with a clinical scenario reminiscent of MEN type 2, in spite of the fact that mos expression is not detectable in most tumors from MEN 2 patients (Schulz et al., 1992) . Hence, there appear to be some disparities between mice and humans with regards to genetic changes associated with MTC, but these are likely to re¯ect species dierences in initiating events in oncogenesis. The models should nonetheless be valuable for analyses of the multiple steps in neoplastic progression. Although ras mutations are rare in human MTC, the rascal transgenic mouse model of MTC should prove to be a valuable tool similar to transgenic mouse models in which Tag leads to a variety of tumor cell types, allowing analyses of sequential cellular changes and additional genetic events required for tumorigenesis in rascal transgenic mice.
It is unlikely that expression of activated ras alone is sucient to initiate tumorigenesis. Several lineage 3 and 5 mice are tumor free, unilateral tumors are common, and tumors appear with long latency. This implies that at least a second genetic event is necessary for the onset of thyroid C-cell tumorigenesis: either directly induced by ras, such as chromosomal breakage and genomic instability leading to mutations in tumor suppressor genes such as p53 or Rb (Denko et al., 1994) , or an independent stochastic event occurring by chance with increasing age. The high incidence of MTC in thyroids from rascal transgenic mice but not in any normal littermates would favor a direct linkage between expression of activated ras and development of Ccell tumors. The thyroids of most young rascal transgenic mice are microscopically indistinguishable from their normal littermates, but C-cell hyperplasia is evident as a nodule of dysplastic C-cells in the thyroid of one 5 month old mouse. This observation suggests that the tumors do not result simply from polyclonal proliferation of C-cells but rather from clones of transformed cells arising within the thyroid.
In rat models of MTC, the importance of genetic factors in the development of C-cell tumors is re¯ected in a relatively constant tumor incidence in speci®c strains, ranging from 0 ± 9% in low-incidence strains to 16 ± 47% in high-incidence strains; crosses of high-and low-incidence strains produce hybrids with intermediate incidence rates of these tumors. Also, it takes over 2 years for the incidence of MTC to reach its peak in high-incidence rats, and C-cell neoplasms are rare in rats younger than 6 months of age (DeLellis, 1994) . These observations suggest that multiple genetic mutations are required in the rat models, similar to rascal transgenic mice.
The lineage relationship of thyroglobulin-expressing and calcitonin-expressing cells is debatable. C-cells certainly arise from neural crest (Polak et al., 1974) , but whether exclusively so is not certain. Thyroglobulin-positive cells can arise in the ultimobranchial body even when not fused with the central thyroid diverticulum (Williams et al., 1989; Leblanc et al., 1996; Ljungberg and Nilsson, 1985) , but other sources are possible as well. Immunoreactive thyroglobulin and calcitonin can be demonstrated together within the same cells in some cases of human MTC, which are referred to as mixed medullary and follicular thyroid carcinoma (Sobrinho-Simoes et al., 1985) . One ultrastructural study demonstrated both dense core granules (characteristic of C-cells) and endoplasmic reticulum contributing to a follicle within the same medullary carcinoma cell (Kovacs et al., 1994) . These observations suggest that a common stem cell might give rise to both cell types within the thyroid (Kovacs et al., 1994) . In the rascal-induced thyroid tumors, coexpression of thyroglobulin and calcitonin antigens can occur in a subset of cells from some of the thyroid tumors we have analysed. The C-cell hyperplasia occurring in a ®ve month old rascal transgenic also manifested phenotypic features consistent with derivation from both lineages: prominent vacuoles occurring in a majority of calcitonin-positive cells (Figure 4b , c) and low levels of thyroglobulin immunostaining in less than half of the dysplastic cells (data not shown). This again suggests that the two cell types may share a common ancestor. Theoretically, the tumor cells could be taking up thyroglobulin secreted by normal thyroid follicles, although this property would suggest a phenotype similar to that of normal follicular epithelial cells (Kostrouch et al., 1991) . rascal thus may be the ®rst experimental model of mixed medullary and follicular thyroid carcinoma. The presence of well-formed thyroid follicles in papillary tumor outgrowths (Figure 4d) , and intracytoplasmic vacuoles in calcitonin-positive C-cells (Figure 4c ) could also be manifestations of partial neuroendocrine/partial follicular epithelial differentiation. Further studies are required to test this hypothesis.
In summary, the rascal transgenic mice develop normally, and are fertile and long lived. These mice provide the opportunity to study the eects of ras activation and/or ras signaling pathways on thyroid development and oncogenesis, and possibly also provide a model for mixed medullary and follicular thyroid carcinoma. The rascal transgenic mouse model of MTC should be valuable for analyses of sequential cellular changes and additional genetic events required for thyroid tumorigenesis (Baetscher et al., 1991; Vassar and Fuchs, 1991; Cuthbertson and Klintworth, 1988; Glasser et al., 1994) .
Materials and methods
Transgene analysis
The rascal lineages were prepared on a C57BL/66SJL background by DNX, National Transgenic Development Facility (Princeton, NL) which was contracted through the National Institutes of Health. The construct included the rat CT/CGRP promoter and v-Ha-ras p21 coding sequences, followed by the SV40 polyadenylation signal sequences, as shown in Figure 1 . Phosphorimage analysis of Southern blots of EcoRI, BamHI and XbaI digested genomic DNA were carried out according to the manufacturer's instructions (Molecular Dynamics). Random primed probes were labeled with 32 P-dCTP and the Klenow fragment of DNA polymerase I (Boehringer Mannheim). For transgene analysis of genomic DNA, the SV-40 speci®c XbaI ± EcoRI fragment of the rascal transgene (Figure 1 ) was used as a probe. A single BamHI site is present in the construct polylinker 22 bases upstream of the 3' EcoRI site. The haploid copy number was determined by hybridization of the Southern blots with Klenow derived SV40 speci®c probe. The blots were washed twice for 30 min at room temperature in 26SSC/ 0.1% SDS, and twice for 30 min at 0.26SSC/0.1% SDS at 658C. The phosphorimage counts in each BamHI band at 4.0 Kb (full length insertion) was divided by the response given by the unique single copy,¯anking sequence band. Sequencing was performed by the dideoxy method using¯uorescence tagged nucleotide label and an automated reader at the Core Facility at Childrens Hospital, Boston. rascal expression analysis Total RNA was isolated from organs by sedimentation of guanidine isothiocyanate homogenates through CsCl according to standard protocols (Davis et al., 1986) . Northern blots were run on 1% agarose formaldehyde gels, blotted onto Nytran membranes (S&S) and hybridized with SV40 probe in 50% formamide at 428C overnight as described (Davis et al., 1986) . RT ± PCR was performed following DNAse I treatment of total RNA. DNAse treatment of RNA prior to reverse transcription eliminated bands due to chromosomal DNA contamination of RNA; this permitted analysis of both full length and spliced messages when we carried out a survey of rascal expression. DNAse digestion proceeded on a total vol of 12 ml for 10 min at 378C on total RNA at 83 mg/ml, 16.6 mM DTT, 83 mM Tris-HCl pH 8.3, 125 mM KCl, 5 mM MgCl. The reaction was raised to 758C for 10 min, placed on ice for 5 min, and split into two 6 ml aliquots. Three ml of a core reaction mix containing RNAguard (Pharmacia) at 8.3 U/ml, 1.67 mM each of dATP, dGTP, dCTP and dTTP, and 333 mM random hexamers (pdN 6 Pharmacia) was then added to each 6 ml reaction, and then 1 ml each of water (minus RT) or of M-MuLV reverse transcriptase 200 U/ml (plus RT) to the respective reactions. Reverse transcription proceeded at 378C for 40 min, and was then placed on ice for immediate use, or stored at 7708C. PCR was carried out on 1.0 ml of the 7RT and +RT reactions using HotTub polymerase (Amersham) in the manufacturer's supplied buer @ 0.15 U/ml in 10 ml reactions with dNTPs @ 200 mM ®nal concentration. The primers chosen for ampli®cation of rascal were 695 (forward): TGCTCCCATTCATCAGTTC; and R8 (reverse): ACCAAGTCCTTTGAAGACAT. Mouse beta actin primers were GTGGGCCGCTCTAGG-CACCA and TGGCCTTAGGGTTCAGGGGG, as described previously (Sunday et al., 1994) . rascal ampli®cation began at 958C for 5 min, followed by 35 cycles of 938C for 1 min, 558C for 1 min, 728C for 45 s, and ®nishing at 728C for 7 min. Actin ampli®cation was carried out for 20 cycles using an identical protocol as for rascal ampli®cation except for a 30 s extension at 728C. For Southern blots of RT ± PCR products, the 364 base pair PCR product corresponding to the spliced transgene (Figure 1 ) was used to generate radiolabeled probe.
Histopathology, antisera and immunohistochemical analyses
Mouse tissues were harvested and placed immediately in 4% paraformaldehyde in phosphate-buered saline (PBS) for overnight ®xation, followed by routine processing into paran blocks; this processing is optimal for preservation of morphology without any loss of immunogenicity for the antigens being studied. For routine histopathological analyses, 3 mm paran sections were stained with hematoxylin and eosin (H&E).
Anti-rat calcitonin antiserum and rat calcitonin peptide were purchased from Peninsula Laboratories. Anti-human thyroglobulin was purchased from Dako Laboratories, Inc. (Santa Barbara, CA); bovine thyroglobulin was obtained from Sigma Chemical Co. (St Louis, MO). Immunohistochemistry was performed on serial 3 mm sections using the avidin-biotin complex (ABC) immunoperoxidase technique according to the manufacturer's speci®cations (Vector Laboratories, Inc., Burlingame, CA) with several modifications in the protocol. In brief, paran sections were placed on Superfrost/Plus slides (Fisher Scienti®c, Pittsburgh, PA) and baked for 1 h at 658C. Sections were dewaxed in xylenes, rehydrated in sequential ethanols, and then washed in PBS. All steps were carried out at room temperature unless stated otherwise. Tissues were permeabilized in Triton X-100 (0.3% in PBS) for 10 min, then blocked with a 1 : 80 dilution of normal goat serum for 20 min. Primary rabbit antisera were applied overnight at 48C using optimal dilutions (1 : 2500 ± 10 000 for thyroglobulin and 1 : 2500 ± 5000 for calcitonin) prepared in PBS containing 2% bovine serum albumin. After washing in PBS, a 1 : 200 dilution of biotinylated goat anti-rabbit lgG was applied to tissue sections for 2 h at 48C. Endogenous peroxidase was then blocked by a 30 min treatment with hydrogen peroxide in methanol (0.03% v/v). After washing, sections were incubated with the standard avidin-biotin complex reagent for 45 min. Slides were developed by incubation with diaminobenzidine (25 mg per 100 ml PBS containing 0.03% peroxide) for 5 min and counterstained with 2% aqueous methyl green prior to dehydration in ethanols, clearing in xylenes, and coverslipping with Permount (Sigma Chemical Co., St Louis, MO).
Control slides were run in parallel using either normal rabbit serum, or diluted antisera preabsorbed with speci®c antigen: 10 mg/ml of rat calcitonin with 1 : 5000 dilution of anti-calcitonin antiserum ; and 10 ± 100 mg/ml of bovine thyroglobulin with 1 : 10 000 dilution of anti-human thyroglobulin.
Slides were reviewed in depth by one pathologist (MES) and positive slides were re-reviewed by Dr Ronald DeLellis. Tumors were scored according to a scale system: (+) for 55% of tumor with cytoplasmic staining; (+) for 5 ± 25% of tumor with immunostaining; (++) for 25 ± 50% immunostaining; (+++) for 50 ± 75% of tumor staining; and (++++) for 475% of tumor cells staining positively.
In situ hybridization
In situ hybridization was carried out using cRNA probes. 33 P-dCTP was used to label the sense and antisense cRNAs: the probe used included only the 0.8 kb SV40 polyadenylation signal sequence which is uniquely present in the rascal transgene (Figure 1) . Hybridization was carried out using 3 mm paran sections on Superfrost Plus slides. Sections were dewaxed and rehydrated, immersed in 4% paraformaldehyde/PBS for 5 min, followed by a 15 min immersion in 0.3% Triton X-100/PBS. After three washes in PBS (2 min each), the slides were incubated for 20 min in Proteinase K (1 mg/ml in 0.1 M Tris-HCl pH 8.0 and 50 mM EDTA at 428C to improve penetration of the hybridization probes). Slides were treated for 5 min with 4% paraformaldehyde/ PBS to arrest proteolysis and decrease the loss of mRNA from the sections during the subsequent steps. After three washes in PBS, sections were incubated for 5 min in triethanolamine, 0.1 M pH 8.0, followed by 10 min in freshly prepared 0.25% acetic anhydride in triethanolamine, 0.1 M pH 8.0 to reduce background, then transferred to 50% formamide/26SSC at 378C for 15 to 45 min. Sections were drained, but not dried, prior to application of *20 ml of the hybridization mixture, containing hybridization buer (50% formamide, 26SSC, 10% dextran sulfate, 0.25% bovine serum albumin, 0.25% ®coll 400, 0.25% polyvinyl-pyrrolidine (PVP) 360, 0.5% SDS, 250 mg/ml denatured salmon sperm DNA) and cRNA probe at a concentration of 5610 4 c.p.m./ ml buer. Tissue sections were covered with glass coverslips and incubated in a moist chamber at 508C for 16 ± 18 h to allow hybridization. Coverslips were removed by immersion in 46SSC at room temperature, then sections were washed three times in 46SSC with gentle shaking at 428C over a total time period of 1 h. Sections were then treated for 30 min at 428C with RNAse A (Sigma) (20 mg/ml in 0.5 M NaCl, 10 mM Tris-HCl pH 7.4, 10 mM EDTA pH 8.0), followed by washing twice with 26SSC at 428C for 30 min. Sections were dehydrated in graded ethanols containing 0.3 M ammonium acetate and air dried before autoradiography using NTB-2 emulsion (Kodak) as described previously (Sunday, 1991) . After exposure for 14 ± 24 days, slides were developed for 2.5 min in D-19 (Kodak), washed for 30 s in 2% acetic acid, and cleared in Kodak Fixer for 5 min. After counterstaining with H&E, slides were analysed by both bright®eld and dark®eld microscopy.
Ultrastructural analyses
Thyroid tumors were carefully separated from adjacent normal thyroid, minced into 1 mm 3 cubes and ®xed in 2.5% glutaraldehyde/1% paraformaldehyde for 3 h prior to routine processing for transmission electron microscopic analyses.
Abbreviations CGRP, calcitonin gene-related peptide; H&E, hematoxylin and eosin; MTC, medullary carcinoma of the thyroid; PBS, phosphate-buered saline; RT ± PCR, reverse transcription polymerase chain reaction; SCLC, small cell carcinoma of the lung; Tag, SV40 large T antigen.
